Why buy this course?

The course you are looking at is not like any other e-Learning course you have ever taken.
Watch this short video to learn why!

FDA Requirements for Prognostic Tests Assessing Chronic Kidney Disease Progression

$9.99

Gain expert insight into the FDA’s new classification for prognostic tests that assess chronic kidney disease (CKD) progression. This course details the specific regulatory requirements, including special controls and labeling standards, for Class II devices. Learn actionable steps for compliance, clinical validation, and the potential risks of non-compliance. Essential for manufacturers and stakeholders involved in CKD diagnostic technology, this training ensures your products meet both safety and legal standards for market access.

In this course you will learn the following:
* Understand the FDA’s rationale for classifying CKD prognostic tests as class II devices.
* Identify the special controls and general controls required for compliance.
* Implement the necessary design, validation, and labeling requirements.
* Recognize the legal and regulatory consequences of failing to comply with the final rule.

NOTE: Unless otherwise indicated, all course purchases are for access to the course for a period of 1-year. At the end of the one year term, the course will be set to “inactive”.

Why This Course is Important
Without this training, you may miss critical FDA requirements, risk costly delays, or face legal penalties that could prevent your CKD prognostic tests from entering the market.

Course Details
This is a self-paced eLearning course based on the Federal Register Document titled Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Prognostic Test for Assessment of Chronic Kidney Disease Progression.

Key regulatory references include:

Course SKU
FR-26-2107-1

About Benchmarks:

Are you ready for this regulation? Use this benchmark to find out.

Each benchmark is build directly for the federal regulation.  They reflect the learning objectives of the related course.

The benchmark is not a “trivia test” – they help you evaluate your readiness to apply the new regulation.

Contact us for more information and/or personalized benchmarks for your specific organization/industry.

FDA Requirements for Prognostic Tests Assessing Chronic Kidney Disease Progression

Gain expert insight into the FDA’s new classification for prognostic tests that assess chronic kidney disease (CKD) progression. This course details the specific regulatory requirements, including special controls and labeling standards, for Class II devices. Learn actionable steps for compliance, clinical validation, and the potential risks of non-compliance. Essential for manufacturers and stakeholders involved in CKD diagnostic technology, this training ensures your products meet both safety and legal standards for market access.

In this course you will learn the following:
* Understand the FDA’s rationale for classifying CKD prognostic tests as class II devices.
* Identify the special controls and general controls required for compliance.
* Implement the necessary design, validation, and labeling requirements.
* Recognize the legal and regulatory consequences of failing to comply with the final rule.

NOTE: Unless otherwise indicated, all Benchmarks are free of charge!

Why This Course is Important
Without this training, you may miss critical FDA requirements, risk costly delays, or face legal penalties that could prevent your CKD prognostic tests from entering the market.

Course Details
This is a self-paced eLearning course based on the Federal Register Document titled Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Prognostic Test for Assessment of Chronic Kidney Disease Progression.

Key regulatory references include:

Course SKU
FR-26-2107-1

Replenish your Studio Course Advisor Unit balance here . Please contact frsales@courseavenue.com if you need to purchase more. Talk to use about an Enterprise License to see if that is right for you!

FDA Requirements for Prognostic Tests Assessing Chronic Kidney Disease Progression

$9.99

Why This Course is Important
Without this training, you may miss critical FDA requirements, risk costly delays, or face legal penalties that could prevent your CKD prognostic tests from entering the market.

Course Details
This is a self-paced eLearning course based on the Federal Register Document titled Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Prognostic Test for Assessment of Chronic Kidney Disease Progression.

Key regulatory references include:

Course SKU
FR-26-2107-1

Gain expert insight into the FDA’s new classification for prognostic tests that assess chronic kidney disease (CKD) progression. This course details the specific regulatory requirements, including special controls and labeling standards, for Class II devices. Learn actionable steps for compliance, clinical validation, and the potential risks of non-compliance. Essential for manufacturers and stakeholders involved in CKD diagnostic technology, this training ensures your products meet both safety and legal standards for market access.

In this course you will learn the following:
* Understand the FDA’s rationale for classifying CKD prognostic tests as class II devices.
* Identify the special controls and general controls required for compliance.
* Implement the necessary design, validation, and labeling requirements.
* Recognize the legal and regulatory consequences of failing to comply with the final rule.

Related products